is cagrilintide a glp 1 Semaglutide, glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit The next frontier in metabolic

What is the point of living longer if you don't enjoy it

A phase II study of depsipeptide in refractory metastatic renal cell cancer

Lynn Baxter, head of North America at ViiV Healthcare, called Dovatos composition an important consideration for young people who will require lifelong treatment. April 5 Product: AstraZeneca and Daiichi Sankyos Enhertu Indication: HER2-positve solid tumors AstraZeneca and Daiichi Sankyo notched another victory for Enhertu on Friday, as the antibody-drug conjugate (ADC) became the first approved tumor-agnostic HER2-directed therapy and the first ADC to win such an indication, according to its makers

The evidence for this approach is limited but growing